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 This research purpose is to estimate the dose distribution of BNCT in 
water phantom. Some common methods in the treatment of cancer such 
as brakhiterapi, surgery, chemotherapy, and radiotherapy still have the 
risk of damaging healthy tissue around cancer cells. BNCT is a 
selectively-designed technique by targeting high-loaded LET particles to 
tumors at the cellular level. BNCT proves to be a powerful method of 
killing cancer without damaging normal tissue. The source of the 
neutron used from the cyclotron dose in water phantom with the size of 
30 cm x 30 cm x 30 cm was calculated using PHITS program. The result 
from the simulation is that boron water panthom has a dosimetri higher 
than phantom water without boron. 
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1. INTRODUCTION 
WHO released data showing in 2015 as 
many as 8.8 million people died from cancer, 
with details of lung cancer (1.69 million 
deaths), liver (788,000 deaths), colorectal 
(774,000 deaths), stomach (754,000 deaths), 
and Breast cancer (571,000 deaths). That 
number makes cancer a major cause of both 
global deaths [1].  
According to data from the Ministry of 
Health of Indonesia in 2013, the prevalence 
of cancer in the population of all ages in 
Indonesia is 1.4 ‰ or estimated to be around 
347 792 people. Cervical cancer and breast 
cancer is the highest prevalence of cancer in 
Indonesia in 2013, which amounted to 0.8 ‰ 
of cervical cancer and breast cancer of 0.5 
‰. Province D.I. Yogyakarta has the highest 
prevalence for cancer, which is 4.1 ‰. Based 
on an estimated number of cancer patients of 
Central Java Province and East Java 
Province is province with estimation of 
cancer patient mostly, that is about 68.638 
and 61.230 people[2]. 
                                                    
 E-mail: maimanah.mae@gmail.com 
Cancer is a group of diseases 
characterized by the growth and spread of 
abnormal cells that are not controlled. If the 
spread is uncontrolled, cancer can cause 
death. Cancer is caused by internal factors 
and external factors. Internal factors cause 
cancer such as inherited genetic mutations, 
hormones, and immune conditions. While 
external factors include smoking habits, 
infectious organisms, and unhealthy diets 
[3]. Based on previous statistical data it is 
known that the number of cases and deaths 
from cancer will continue to increase from 
year to year, for it needs an early diagnosis 
and appropriate treatment in order to 
suppress the increase in number. 
Common methods of treating cancers 
such as brachytherapy, surgery, 
radiotherapy, and chemotherapy still have 
risks to be considered that can damage 
normal surrounding tissue [4] [5][9]. 
Therefore a method of treatment that can kill 
cancer without damaging normal tissue is 
required. 
A promising method in the treatment of 
malignant tumors, especially incurable brain 
tumors, is Boron Neutron Capture Cancer 
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Therapy (BNCT), which is particularly 
interesting because of the direct selective 
action on tumor cells [6]. BNCT is based on 
the ability of non-radioactive boron-10 
isotopes to capture thermal neutrons with 
very high probability. This nuclear reaction 
produces two high-LET particles (He-4 and 
Li-7) with a limited network range on the 
diameter of a single cell. It is possible to 
target tumor cells and destroy them while 
maintaining other healthy tissues containing 
boron-10 lower than tumor cells. As 
radiotherapy at the cellular level, BNCT can 
provide very precise dose delivery which 
makes it possible to treat tumors and reduce 
side effects [7]. The BNCT treatment 
process was performed in two steps, first the 
patient was injected with drug-localized 
boron-containing tumor, then the target 
volume (cancer cell) was irradiated with 
thermal or epi-thermal neutrons [8][20]. This 
method was first used in 2001 in Pavia, Italy 
[6]. In order for cancer treatment with BNCT 
method to succeed and effectively kill tumor 
cells spread in healthy tissue, boron 
concentration sent to all tumor cells must be 
selective. The recommended amount of 10B 
is ~ 20 μg/g tumor or ~ 109 atom/cell[10]. 
During this time the neutron beam is 
obtained from the nuclear fission reactor due 
to the limitations of this technique it can not 
be applied in the hospital [11]. Therefore, to 
support the application of cancer treatment 
methods with BNCT at the hospital 
developed a source of accelerator-based 
neutron, that is, cyclotron. Cycllotron HM-
30 MeV with file forming assembly has been 
made at KURRI in cooperation with 
Sumitomo Heavy Industries, Ltd. A proton 
beam with a current of 1.1 mA and an energy 
of 30 MeV obtained at a cyclotron weighing 
60 t[6][12][19]. 
During the BNCT treatment, the 
absorbed dose is sent to normal tissues and 
tumors. The results of irradiation depends on 
the spatial, spectral and characteristic angles 
of the neutron beam as well as on the 
geometry and composition of the target [13]. 
When neutrons are about tissue, they not 
only react with boron neutrons but also react 
with other nuclei. An effective biological 
dose will depend on the relative biological 
effectiveness (RBE) and biological 
effectiveness of the compound (CBE) for 
different components in each case [14]. 
There are four dose components that 
include[15][16][17][18]: 
1. Photon Dose 
Photon yield of the reaction (n, γ), 
mainly occur after thermal neutrons on the 
structure of the material, but also in organic 
materials dominated by photons with energy 
of 2.2 MeV from the reaction of 1H (n, γ) 2H 
(0.332 barn cross section; all sections for 
0.025 eV thermal energy neutrons). 
2. Neutron Dose 
Dose fast neutron storage or epithermal 
neutrons by elastic scattering process in 
hydrogen. Due to almost the same mass of 
neutron and protons, so-called recoiling 
proton' can be obtained from the interaction 
of 1H (n, n ') 1H. The proton energy depends 
on the incident neutron energy and the 
scattering process. 
3. Proton Dose 
The thermal neutron capture may also 
lead to the production of protons. In a 
nitrogen-containing material, the reaction is 
14N (n, p) 14C with a cross section of 1.82 
barn (V). Classified as a separate dose 
component. Protons are emitted with 560 kV 
kinetic energy and range on a micrometer 
scale. 
4. Boron Dose 
Dose of capture 10B due to reaction 10B 
(n, α) 7Li. 
The purpose of this research is to 
estimate the spread of the dose of proton, 
nitrogen, boron and photon in water phantom 
with source of neutron from cyclotron where 
the distribution of dose in water phantom is 
known and simulated using tally program 
Particle and Heavy Ion Transport Simulation 
(PHITS). PHITS is software development 
from Monte Carlo Particle and Heavy Ion 
Transport code System. Several new tallyes 
were included to estimate the relative 
biological effects (RBE) that support the 
determination of the dose of BNCT 
distribution. 
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2. MATERIALS AND METHODS 
2.1 Water Phantom Geometry 
The first step of the research is to make 
water phantom geometry. Water phantom 
used contains D2O (Deutirium Oxide) with a 
size of 30 cm x 30 cm x 30 cm, wrapped by 
acrylic glass with 1 cm thick around. This 
study used two varian, that is, water phantom 
without boron and water phantom that has 
been given boron. 
ss 
Fig.1 Water panthom geometry without boron 
Figure 1 showed geometry where part 1 
is a water phantom, part 2 is acrylic glass, 
while part 3 is air. 
2.2 Shooting Spectrum Neutron 
The neutrons spectrum emerging from 
the collimator are shot at the water phantom 
from the left. The water phantom was 
created or divided into 6 slices from the 
direction of the neutron shooting, so dose 
distribution of each specified depth can be 
seen. 
 
Fig 2. Shooting spectrum neutron at water phantom 
2.3 Calculation of Dose 
Calculation of dose distribution using 
[T-Deposit] tally  of PHITS program. 
3. RESULTS AND DISCUSSION 
3.1. Water Phantom With Boron 
When neutrons pound the water 
phantom, neutrons will interact with the 
material contained therein. In phantom water 
with boron, neutrons will interact with boron 
and produce alpha particles and lithium 
nuclei. In addition to these two particles also 
emit gamma (photon). 
 
Fig 3. Dose distribution in water phantom with boron 
In Figure 3 doses visible are only doses 
of alpha and lithium which are both a boron 
dose while the doses of photons, neutrons 
and protons do not exist. Large doses are 
described in Table 1. 
Table 1. Dose distribution of water phantom with 
boron 
Dose Type Gy/source 
Photon 0 
Alpha  27,6795277 
Lithium 15,7941626 
Proton 0 
Neutron 0 
 
 
Fig 4. Dose multiplier each region in water 
phantom       with boron 
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Figure 4 shows that the photon dose is 
much higher than the neutron dose. Neutron 
dose and photon dose in each region are 
different where the highest dose in region 4 
and the lowest in region 1 with dose details 
are found in Table 2. 
Table 2. Dose of neutron and gamma (photon) in 
each region of water phantom with boron 
Region Dn(Gy/source) Dγ(Gy/source) 
1 4,72E-04 3,91E+01 
2  4,22E-01 7,68E+01 
3 9,64E+00 1,78E+02 
4 1,51E+02 2,57E+02 
5 3,20E+01 1,18E+02 
6 5,58E+00 5,56E+01 
 
3.1 Water Phantom Without Boron 
In water phantom without boron, pure 
water phantom contains only D2O. 
 
Fig 5. Dose distribution in water phantom without 
boron 
Figure 5 shows that the visible dose 
distributions are alpha dose and proton dose, 
while for doses of photons, lithium, and 
neutrons does not exist. The dose of proton is 
higher than the alpha dose. Large doses are 
described in Table 3. 
Table 3. Dose distribution of water phantom without 
boron 
Dose Type Gy/source 
Photon 0 
Alpha  0,0210285 
Lithium 0 
Proton 0,12711041 
Neutron 0 
 
 
Fig 6. Dose multiplier each region in water 
phantom       with boron 
Unlike the water phantom containing 
boron, Figure 6 shows that the water 
phantom without the boron dose of neutrons 
values higher than the dose of photons. The 
dose of each region is also different but not 
too conspicuous. The dose decreases with 
increasing depth. Large doses of each region 
are described in Table 4. 
Table 4. Dose of neutron and gamma (photon) in each 
region of water phantom without boron 
Region Dn(Gy/source) Dγ(Gy/source) 
1 2,44E+02 5,61E+00 
2  1,40E+02 3,52E+00 
3 7,70E+01 3,51E+00 
4 4,75E+01 2,84E+00 
5 2,76E+01 2,01E+00 
6 1,80E+01 1,67E+00 
 
4. CONCLUSION AND REMARKS 
From that research can be 
concluded that water phantom boron-
containing has dosimetri higher than 
in water phantom without boron.  
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